Free Trial
→ Today's free pick (on me) (From Behind the Markets) (Ad)tc pixel
NASDAQ:UTRS

Minerva Surgical Earnings Date & Estimates

Minerva Surgical logo
$0.0001 0.00 (0.00%)
As of 11/9/2026 01:25 PM Eastern

Minerva Surgical is estimated to report earnings on Tuesday, November 17, 2026.

Research:Profile

Upcoming Earnings Announcement

Announcement Date
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Minerva Surgical

Minerva Surgical is expected to post earnings of -$8.8067 per share on revenue of $12.15 million. Minerva Surgical last reported on November 13, 2023, posting -$0.81 per share and beating the -$1.00 consensus estimate. Minerva Surgical has beaten the consensus EPS estimate in 3 of its last 7 quarters.

Consensus Estimates

Consensus EPS
-$8.8067
Expected Revenue
$12.15 million

Recent Track Record

Last Reported
Q3 2023
Last Quarter EPS
-$0.81 (Beat by +$0.19)
Last Quarter Revenue
$11.97 million
EPS Beat Rate
3 of last 7 quarters

Prepare for the Earnings Call

Minerva Surgical Earnings FAQ

Minerva Surgical (NASDAQ:UTRS) is estimated to report earnings on Tuesday, November 17, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Minerva Surgical to post earnings of -$8.8067 per share for the quarter.

The consensus revenue estimate for Minerva Surgical is $12.15 million for the quarter.

Minerva Surgical Earnings Headlines

Minerva Surgical Inc.
January 10, 2024  |  thestreet.comhttps://www.thestreet.com/quote/UTRS
Why Is Minerva Surgical (UTRS) Stock Down 50% Today?
December 18, 2023  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/why-is-minerva-surgical-utrs-stock-down-50-today-1032909053
My public warning after 55 years of watching the markets
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel
November 10 at 1:00 AM  |  Weiss Ratings (Ad)
Minerva Surgical Inc UTRS
December 17, 2023  |  morningstar.comM
Minerva Surgical, Inc.: Minerva Surgical Reports Third Quarter 2023 Financial Results
November 14, 2023  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2023-11/60655170-minerva-surgical-inc-minerva-surgical-reports-third-quarter-2023-financial-results-399.htm
Minerva Surgical GAAP EPS of -$0.81 misses by $0.27, revenue of $12M misses by $1.93M
November 14, 2023  |  msn.comhttps://www.msn.com/en-us/money/markets/minerva-surgical-gaap-eps-of-081-misses-by-027-revenue-of-12m-misses-by-193m/ar-AA1jUxIF
See More Minerva Surgical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Minerva Surgical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Minerva Surgical and other key companies, straight to your email.

About Minerva Surgical

Minerva Surgical (NASDAQ:UTRS) is a medical device company focused on women’s health. The company develops and commercializes technologies intended to diagnose and treat conditions affecting the uterus, with an emphasis on abnormal uterine bleeding, a common condition that can significantly affect quality of life.

Its product portfolio includes the Minerva ES Endometrial Ablation System, which uses controlled energy to treat heavy menstrual bleeding, and the Symphion System, a hysteroscopic tissue-removal device used in procedures involving uterine fibroids and polyps. The company has also offered the Genesys HTA System, an endometrial ablation technology designed for use in treating abnormal uterine bleeding.

Minerva Surgical sells its products primarily through healthcare providers, hospitals, and surgical facilities, serving the U.S. market and select international markets. The company was founded in 2008 and is headquartered in Redwood City, California. Its business has historically centered on providing less-invasive alternatives to more extensive surgical procedures in gynecology.

View Minerva Surgical Profile
Earnings Tools